The Future of Breast Cancer Treatment is Now!

Print icon

Clinical trials are the means by which doctors and researchers work toward providing newer, better and more innovative health care treatments. This is especially true as the health care community works toward treating cancer. As the charter member of the Memorial Sloan Kettering Cancer Alliance, the Hartford HealthCare Cancer Institute is giving patients access to hundreds of clinical trials. Dr. Patricia DeFusco is the newly-appointed medical director of the Hartford HealthCare Cancer Institute Breast Program

Q: What is the importance of cancer clinical trials? 

A: Clinical trials are the means by which we learn about new therapies, and also learn about the application of very novel therapies to very specific subsets of patients.

Q: What’s new in clinical research?

A: One of the exciting trials we’re involved with Memorial Sloan Kettering is called the Impact Trial. This is the trial where we’re sending off tumor specimens in patients with newly-diagnosed metastatic cancer. Those tumor specimens are analyzed for a number of different pathways. If there is an abnormality found in one of those pathways, it may help to make the patient eligible for a specific clinical trial looking at a drug that might alter that pathway.

Q: Who is the best candidate for something like this?

A: At Hartford HealthCare, we’re doing this quite a bit in the breast program by looking at women with newly-diagnosed metastatic breast cancer. We know that there are differences in the pathways between the initial diagnosis and the presence of metastatic disease. Trying to exploit those differences to find better therapies is what we’re trying to find.

Learn more about locally-available cancer clinical trials here from the Hartford HealthCare Cancer Institute and the Memorial Sloan Kettering Cancer Institute. 


What's New

Pancreatic Cancer

Free Pancreatic Care Webinar June 11

The fourth leading cause of cancer death in both men and women, pancreatic cancer, is an aggressive form of the disease that often exhibits few symptoms until it is advanced. Approximately 57,000 Americans will be diagnosed with it this year, according to the American Cancer Society. About 47,000 will die...

Jeffrey A. Flaks

A Message From Hartford HealthCare CEO Jeffrey Flaks

With the concerns about coronavirus and COVID-19, I want to assure you that Hartford HealthCare is doing everything possible to protect the safety and well-being of the people and the communities we serve, and our team of healthcare providers. Our goal is to be ready and prepared for whatever is...

Quite Smoking

Trying to Quit Smoking? Here’s Some Help

Editor’s note: Initial studies have shown that if you smoke and get COVID-19, you’re 14 times more likely than nonsmokers to require intensive treatment. If you’ve considered stopping smoking, now is a good time. By Ellen Anderson Dornelas, PhD Director, Cancer Care Delivery and Disparities Research Hartford Healthcare Cancer Institute...

Pancreatic Cancer Recovery

How to Manage Pancreatic Cancer Treatment’s Side Effects

A pancreatic cancer survivor is any person who is actively facing pancreatic cancer or has faced it at some point. It could be someone who has completed treatment or a patient actively receiving chemotherapy for a limited or long-term management of their disease. Patients treated with chemotherapy experience a variety...

Breast Cancer Awareness

The New Normal for Breast Cancer Survivors

The word “patient” stems from the Latin word patiens, meaning sufferer. Until recently, a diagnosis of cancer conveyed a sense of victimhood and loss of control, hence labels such as “cancer patient” or “cancer victim.” Despite good intentions, these terms left those with a cancer diagnosis feeling isolated and somehow...